Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
重组凝血因子IX-Fc融合蛋白(rFIXFc)在B型血友病患者的1/2a期研究中显示出安全性和持久活性。
期刊:Blood
影响因子:23.1
doi:10.1182/blood-2011-07-367003
Shapiro, Amy D; Ragni, Margaret V; Valentino, Leonard A; Key, Nigel S; Josephson, Neil C; Powell, Jerry S; Cheng, Gregory; Thompson, Arthur R; Goyal, Jaya; Tubridy, Karen L; Peters, Robert T; Dumont, Jennifer A; Euwart, Donald; Li, Lian; Hallén, Bengt; Gozzi, Peter; Bitonti, Alan J; Jiang, Haiyan; Luk, Alvin; Pierce, Glenn F